Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
12/2014
12/04/2014US20140357691 Methods of Treating Ocular Diseases Using Derivatives of Lipoic Acid
12/04/2014US20140357670 Dihydropyridinone mgat2 inhibitors
12/04/2014US20140357667 Treatment of cerebral palsy impaired speech in children
12/04/2014US20140357661 Chemical compounds
12/04/2014US20140357658 Opioid agonist/opioid antagonist/acetaminophen combinations
12/04/2014US20140357648 Therapeutic approaches for treating alzheimer's disease
12/04/2014US20140357639 Imidazole derivatives as PDE10 enzyme inhibitors
12/04/2014US20140357637 Substituted annulated pyrimidines and triazines, and use thereof
12/04/2014US20140357634 Substituted 4-aminocyclohexane derivatives
12/04/2014US20140357632 Benzopiperazine derivatives as cetp inhibitors
12/04/2014US20140357630 Phenylacetic Acid Compound
12/04/2014US20140357626 Hetero-Bicyclic Derivatives As HCV Inhibitors
12/04/2014US20140357621 Organic Compounds
12/04/2014US20140357606 Organic compounds
12/04/2014US20140357602 Combination Therapies For Treating Metabolic Disorders
12/04/2014US20140357599 Novel urea and thiourea derivatives
12/04/2014US20140357595 Methods of preventing and treating recurrence of a hepatitis c virus infection in a subject after the subject has received a liver transplant
12/04/2014US20140357587 Use of Glutaryl Histamine for the Treatment of Respiratory Tract Diseases
12/04/2014US20140357576 Methods for enhancement of muscle protein synthesis
12/04/2014US20140357567 Methods for treating cancers using oral formulations of cytidine analogs
12/04/2014US20140357563 Compositions and Methods for the Generation of Activated Protein C and Methods of Use Thereof
12/04/2014US20140357562 Beta-Arrestin Effectors And Compositions And Methods Of Use Thereof
12/04/2014US20140357557 Cyclodextrin-based polymers for therapeutic delivery
12/04/2014US20140357555 Novel monascuspurpurones, preparation process thereof, and uses of the monascuspurpurones
12/04/2014US20140357551 Organic compounds and their uses
12/04/2014US20140356458 Treatment of sickle cell disease
12/04/2014US20140356457 Novel means and methods for the treatment of hearing loss and phantom hearing
12/04/2014US20140356456 Treating cancer with atr inhibitors
12/04/2014US20140356439 Lipidated glycoprotein particles and methods of use
12/04/2014US20140356428 Tamper resistant dosage form with bimodal release profile
12/04/2014US20140356426 Tamper-resistant dosage form containing one or more particles
12/04/2014US20140356424 Composition for treatment or reduction of symptoms related to premenstrual syndrome (pms), premenstrual disphoric disorder (pmdd), premenopause, menopause or female hormonal disorders, in a pharmaceutical composition containing said form, and process for producing said pharmaceutical form and use of said composition
12/04/2014US20140356420 Micro-particle comprising a protein extract from sweet potato for extending satiety and controlling blood glucose and lipid levels
12/04/2014US20140356414 Targeted Crosslinked Multilamellar Liposomes
12/04/2014US20140356411 Plasmonic-magnetic bifunctional nanotubes for biological applications
12/04/2014US20140356397 Immunogenic Treatment Of Cancer
12/04/2014US20140356378 BMP-1 Procollagen C-Proteinase for Diagnosis and Treatment of Bone and Soft Tissue Defects and Disorders
12/04/2014US20140356376 Anti-wall teichoic antibodies and conjugates
12/04/2014US20140356373 Methods and compositions for treating lupus
12/04/2014US20140356372 Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an IL-4R inhibitor
12/04/2014US20140356360 Piperazinyl derivatives for the treatment of cancer
12/04/2014US20140356355 Il-17 receptor a antigen binding proteins
12/04/2014US20140356352 COMBINATION THERAPY OF AN AFUCOSYLATED CD20 ANTIBODY WITH A CD79b ANTIBODY-DRUG CONJUGATE
12/04/2014US20140356350 Combination therapy to prevent dcis formation and progression to breast cancer
12/04/2014US20140356325 Novel 2'-c-methyl nucleoside derivative compounds
12/04/2014US20140356322 Compounds & Methods for the Enhanced Degradation of Targeted Proteins & Other Polypeptides by an E3 Ubiquitin Ligase
12/04/2014US20140356321 Materials and methods for treatment of liver cancer
12/04/2014US20140356294 Dosage that is safeguarded from abuse
12/04/2014US20140356292 In vivo screening method of therapeutic agent for memory/learning dysfunctions by schizophrenia
12/04/2014US20140356281 DUAL SPECIFIC BINDING PROTEINS DIRECTED AGAINST IL-1 and/or IL-17
12/02/2014US8901293 Useful combinations of monobactam antibiotics with beta-lactamase inhibitors
12/02/2014US8901176 Methods for treatment of Parkinson's disease
12/02/2014US8901175 Use of opioids or opioid mimetics for the treatment of resistant cancer patients
12/02/2014US8901167 Product and process for inhibition of biofilm development
12/02/2014US8901158 Treatment of bipolar disorder
12/02/2014US8901147 Bi-heteroaryl compounds as Vps34 inhibitors
12/02/2014US8901138 Sulfoximine substituted quinazolines for pharmaceutical compositions
12/02/2014US8901137 Methods of treating cancer using pyridopyrimidinone inhibitors of PI3K and mTOR in combination with autophagy inhibitors
12/02/2014US8901124 Pyridazine amide compounds useful as SYK inhibitors
12/02/2014US8901114 Oxathiazine derivatives substituted with carbocycles or heterocycles, method for producing same, drugs containing said compounds, and use thereof
12/02/2014US8901109 Quercetin-containing compositions
12/02/2014US8901108 Arylsulfonyl pyrazoline carboxamidine derivatives as 5-HT6 antagonists
12/02/2014US8901106 Imidazole prodrug LXR modulators
12/02/2014US8901105 Prodrug derivatives of (E)-N-methyl-N-((3-M ethylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide
12/02/2014US8901098 Antisense modulation of GCCR expression
12/02/2014US8901073 Compounds and their effects on feeding behaviour
12/02/2014US8901072 Glycopeptide and lipoglycopeptide antibiotics with improved solubility
12/02/2014US8901071 Compounds and their use
12/02/2014US8901070 Pharmaceutical compositions comprising pore-forming proaerolysin protein (PRX302)
12/02/2014US8900638 Solid preparation comprising alogliptin and metformin hydrochloride
12/02/2014US8900617 Bio-Remodable Bone Augmentation device and method
12/02/2014US8900615 Drug delivery system
12/02/2014US8900601 Permeable mixtures, methods and compositions for the skin
12/02/2014US8900590 Anti-hemagglutinin antibody compositions and methods of use thereof
12/02/2014US8900579 Siglec-15 antibodies in treating bone loss-related disease
12/02/2014US8900570 Treatment of IBD and IBS using both probiotic bacteria and fermented cereal as treatment effectors
12/02/2014US8900569 Method of treating diarrhea in a canine
12/02/2014US8900568 Method of treating diarrhea in a canine
12/02/2014US8900566 Hepatitis C virus inhibitors
12/02/2014US8900565 Indole derivatives as inhibitors of histone deacetylase
12/02/2014US8900564 Vaccine composition comprising an antigen and a peptide having adjuvant properties
12/02/2014US8900552 Treatment of glycogen storage disease type II
12/02/2014US8900208 Gas mist pressure bath system
11/2014
11/27/2014US20140351963 MiRNAs Useful to Reduce Lung Cancer Tumorigenesis and Chemotherapy Resistance and Related Compositions and Methods
11/27/2014US20140351961 Compositions and methods for treatment of metastatic cancer
11/27/2014US20140351960 Artery- and vein-specific proteins and uses therefor
11/27/2014US20140350452 Method of using laser-induced optoacoustics for the treatment of drug-resistant microbial infections
11/27/2014US20140350107 Use of Pan-PPAR Agonists for Prevention and Treatment of Huntington's Disease and Tauopathies
11/27/2014US20140350076 Induction of exon skipping in eukaryotic cells
11/27/2014US20140350069 Methods and agents to increase therapeutic dystrophin expression in muscle
11/27/2014US20140350050 Pyridine compounds as inhibitors of kinase
11/27/2014US20140350047 Isoform-selective inhibitors and activators of pde3 cyclic nucleotide phosphodiesterases
11/27/2014US20140350033 Ant-ligands molecules and biological applications
11/27/2014US20140350022 Efficacious treatment of NSCLC and predictive clinical marker of the responsiveness of a tumour to a treatment
11/27/2014US20140350020 Ring-fused pyrimidines and triazines and use thereof for the treatment and/or prophylaxis of cardiovascular diseases
11/27/2014US20140350019 Aniline derivatives, their preparation and their therapeutic application
11/27/2014US20140350016 Potent and selective inhibitors of hepatitis c virus
11/27/2014US20140350006 Pyrazolopyridine Derivatives, Preparation Process Therefor And Therapeutic Use Thereof
11/27/2014US20140350005 D2 antagonists, methods of synthesis and methods of use
11/27/2014US20140349996 Pyrimidyl cyclopentanes as akt protein kinase inhibitors
1 ... 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 ... 1151